Adlai Goldberg

@EY_LifeSciences Partner ~ Life is about discovering something new ~ #Innovation, #CGT, #IndividualizedMedicine, #Pointellis #BeatingCancer, #RareDisease

[Adlai Goldberg @adlaigoldberg]

Our industry has come a long way since the first #CGTs were approved, and it continues to make great progress towards scaling these treatments. This @_CellandGene article outlines another way our industry is advancing: https://t.co/wWhCqInDNp

[Adlai Goldberg @adlaigoldberg]

Adhering to regulation and staying compliant is an important path forward for our industry to advance these treatments. It’s even more impressive to see this path established through two players in the industry collaborating. @BioPharmReporter: https://t.co/qatB5yfv7r

[Adlai Goldberg @adlaigoldberg]

Feeling very lucky to be part of this amazing team and how it is truly able to positively impact healthcare and life sciences companies.

[Pamela Spence @PamelaSpence_EY]

Proud to be ranked #1 by HFS in its Top 10 HFS Life Sciences service providers report. According to HFS, EY’s strengths are "strong business growth, ability to deliver client outcomes, talent management, and value creation." Full report available here: https://t.co/3Wp1mlqIiR

[Adlai Goldberg @adlaigoldberg]

It’s not only important to see a leader in the #CGT space make progress in bringing a new treatment to the market, but it’s promising to see this leader explore affordable payment structures in order to increase access to #cellandgenetherapies. @endpts https://t.co/TraedW4e0Z

[Adlai Goldberg @adlaigoldberg]

Technology will play a crucial role in innovating and advancing the #cellandgenetherapy space. I enjoyed reading this article in @FiercePharma that highlights how one #CGT player is leveraging #tech to scale the manufacturing process: https://t.co/zMckVIa3oV

[Adlai Goldberg @adlaigoldberg]

I’ve said it before, and I'll say it again! It is encouraging to see two key players in the #pharma space team up to tackle challenges in #cellandgenetherapies. Expect the #CGT space to progress more quickly as more #collaboration continues. @biopharmadive https://t.co/qsPEvTIrL6

[Adlai Goldberg @adlaigoldberg]

It was a delight to moderate a timely discussion on developing #collaborative delivery networks for #cellandgenetherapies. Watch the @RE_Pharma panel I moderated with leaders from @Microsoft @JNJNews @MARKEN_LLP and @CBM_CDMO here: https://t.co/fL3ZD970NH

[Adlai Goldberg @adlaigoldberg]

Yet another interesting clinical trial to be approved in the #cellandgenetherapy space. I look forward to seeing these treatments move from clinical trials to commercialization. Read more about this latest #CGT clinical trial in @FierceBiotech: https://t.co/JWZpoqcMHu

[Adlai Goldberg @adlaigoldberg]

This article in @Pharma_Intell provides excellent insight into how fast the #CGT space is growing – there’s nearly 3,500 therapies in preclinical and clinical development globally! Now, the industry needs to focus on making these therapies more accessible. https://t.co/DCj0LTtBMG

[Adlai Goldberg @adlaigoldberg]

The cell and gene therapy industry is rising rapidly and a lot of services companies are competing to bring fast, efficient, low-cost operations alongside innovation. While this may be a huge opportunity for #pharma, talent becomes the main challenge. https://t.co/ZzVzra4mEr

[Adlai Goldberg @adlaigoldberg]

Patient input will have a huge impact on key areas of #clinicaltrials such as the design of #technology being used, outcomes, data entries and addressing unmet needs. https://t.co/h3Ojy64vV0

[Adlai Goldberg @adlaigoldberg]

I couldn’t agree more with this article in @BioProcessIntl that we need to develop a commercially viable lifecycle for #CGT that will require greater #collaboration, #DataSharing and #trust to deliver many more therapies to many more people. #genetherapy
https://t.co/Stye8WuN0q

[Adlai Goldberg @adlaigoldberg]

It was a pleasure sitting down with @PharmaTechFocus and @Microsoft’s @drhew to discuss the strong marriage between #BigPharma and #BigTech that is necessary for creating the innovation needed to transform lives. https://t.co/HqNA3WnQ46 #collaboration

[Adlai Goldberg @adlaigoldberg]

This is great news. Advances in #genomics will spur the potentials of #personalizedmedicine and unlock treatment responsiveness providing hope for many patients. https://t.co/VTiIcWvaJb

[Adlai Goldberg @adlaigoldberg]

Fantastic! These new biological insights demonstrate the promise of precision #genomics in cancer treatment and its potential for improved patient care. https://t.co/niILEujSgC

[Adlai Goldberg @adlaigoldberg]

The pandemic has caused an acceleration of tech advancements in most industries, including healthcare, and given our current situation, #digitalhealth will continue to be of relevance in coming years. https://t.co/e4q2RYLADk

[Adlai Goldberg @adlaigoldberg]

The efficacy of treatments lies in the representation of real-world patients in #clinicaltrials. Harnessing data from a diverse patient population is vital for doctors to determine appropriate and safe treatment. https://t.co/Wfl0sx9OQm

[Adlai Goldberg @adlaigoldberg]

Wise words from @OSerani, Johnson & Johnson : “We need to collaborate at the speed of science.”

A call to action for all the key players in the CGT ecosystem to collaborate and share data to help make cell and gene therapies available and affordable. https://t.co/mpv1GepnC3

[Adlai Goldberg @adlaigoldberg]

As a reality TV fanatic, I would LOVE to see #LGBTQ inclusive versions of some of my favorite shows. https://t.co/VQEdQFPcOo

[Adlai Goldberg @adlaigoldberg]

We should always be on the lookout for safer approaches on how we deliver #genetherapy. Reducing toxicities through microRNA could drastically enhance a patient's overall well-being. https://t.co/DcUjZhbMTg #CRISPR